Beside CRP, other inflammation-related parameters, such as white blood cell count, neutrophil/lymphocyte ratio, or erythrocyte sedimentation rate, are potential biomarkers for outcome in rectal cancer patients [64,65]. This evidence concerns the gene CRP and rectal cancer.